Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation

Steve N. Caritis, Hyagriv N. Simhan, Yuan Zhao, Dwight J. Rouse, Alan M. Peaceman, Anthony Sciscione, Catherine Y. Spong, Michael W. Varner, Fergal D. Malone, Jay D. Iams, Brian M. Mercer, John M. Thorp, Yoram Sorokin, Marshall Carpenter, Julie Lo, Susan M. Ramin, Margaret Harper

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Objective: We sought to evaluate in women with twin gestation the relationship between 17-hydroxyprogesterone caproate (17-OHPC) concentration and gestational age at delivery and select biomarkers of potential pathways of drug action. Study Design: Blood was obtained between 24-28 weeks (epoch 1) and 32-35 weeks (epoch 2) in 217 women with twin gestation receiving 17-OHPC or placebo. Gestational age at delivery and concentrations of 17-OHPC, 17-hydroxyprogesterone, progesterone, C-reactive protein (CRP), and corticotrophin-releasing hormone were assessed. Results: Women with higher concentrations of 17-OHPC delivered at earlier gestational ages than women with lower concentrations (P <.001). Women receiving 17-OHPC demonstrated significantly higher (P =.005) concentrations of CRP in epoch 1 than women receiving placebo but CRP values were similar in epoch 2 in both groups. A highly significant (P <.0001) positive relationship was observed between 17-OHPC concentration and progesterone and 17-hydroxyprogesterone concentrations at both epochs. Corticotropin-releasing hormone concentrations did not differ by treatment group. Conclusion: 17-OHPC may adversely impact gestational age at delivery in women with twin gestation.

Original languageEnglish (US)
JournalAmerican Journal of Obstetrics and Gynecology
Volume207
Issue number5
DOIs
StatePublished - Nov 2012

Fingerprint

17-alpha-Hydroxyprogesterone
Gestational Age
Pregnancy
C-Reactive Protein
Corticotropin-Releasing Hormone
Progesterone
Placebos
17-alpha-hydroxy-progesterone caproate
Biomarkers
Pharmaceutical Preparations

Keywords

  • 17-hydroxyprogesterone caproate
  • pharmacodynamics
  • twin gestation

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation. / Caritis, Steve N.; Simhan, Hyagriv N.; Zhao, Yuan; Rouse, Dwight J.; Peaceman, Alan M.; Sciscione, Anthony; Spong, Catherine Y.; Varner, Michael W.; Malone, Fergal D.; Iams, Jay D.; Mercer, Brian M.; Thorp, John M.; Sorokin, Yoram; Carpenter, Marshall; Lo, Julie; Ramin, Susan M.; Harper, Margaret.

In: American Journal of Obstetrics and Gynecology, Vol. 207, No. 5, 11.2012.

Research output: Contribution to journalArticle

Caritis, SN, Simhan, HN, Zhao, Y, Rouse, DJ, Peaceman, AM, Sciscione, A, Spong, CY, Varner, MW, Malone, FD, Iams, JD, Mercer, BM, Thorp, JM, Sorokin, Y, Carpenter, M, Lo, J, Ramin, SM & Harper, M 2012, 'Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation', American Journal of Obstetrics and Gynecology, vol. 207, no. 5. https://doi.org/10.1016/j.ajog.2012.08.001
Caritis, Steve N. ; Simhan, Hyagriv N. ; Zhao, Yuan ; Rouse, Dwight J. ; Peaceman, Alan M. ; Sciscione, Anthony ; Spong, Catherine Y. ; Varner, Michael W. ; Malone, Fergal D. ; Iams, Jay D. ; Mercer, Brian M. ; Thorp, John M. ; Sorokin, Yoram ; Carpenter, Marshall ; Lo, Julie ; Ramin, Susan M. ; Harper, Margaret. / Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation. In: American Journal of Obstetrics and Gynecology. 2012 ; Vol. 207, No. 5.
@article{cc5b2e3c18a24e05a2d8f2526d369803,
title = "Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation",
abstract = "Objective: We sought to evaluate in women with twin gestation the relationship between 17-hydroxyprogesterone caproate (17-OHPC) concentration and gestational age at delivery and select biomarkers of potential pathways of drug action. Study Design: Blood was obtained between 24-28 weeks (epoch 1) and 32-35 weeks (epoch 2) in 217 women with twin gestation receiving 17-OHPC or placebo. Gestational age at delivery and concentrations of 17-OHPC, 17-hydroxyprogesterone, progesterone, C-reactive protein (CRP), and corticotrophin-releasing hormone were assessed. Results: Women with higher concentrations of 17-OHPC delivered at earlier gestational ages than women with lower concentrations (P <.001). Women receiving 17-OHPC demonstrated significantly higher (P =.005) concentrations of CRP in epoch 1 than women receiving placebo but CRP values were similar in epoch 2 in both groups. A highly significant (P <.0001) positive relationship was observed between 17-OHPC concentration and progesterone and 17-hydroxyprogesterone concentrations at both epochs. Corticotropin-releasing hormone concentrations did not differ by treatment group. Conclusion: 17-OHPC may adversely impact gestational age at delivery in women with twin gestation.",
keywords = "17-hydroxyprogesterone caproate, pharmacodynamics, twin gestation",
author = "Caritis, {Steve N.} and Simhan, {Hyagriv N.} and Yuan Zhao and Rouse, {Dwight J.} and Peaceman, {Alan M.} and Anthony Sciscione and Spong, {Catherine Y.} and Varner, {Michael W.} and Malone, {Fergal D.} and Iams, {Jay D.} and Mercer, {Brian M.} and Thorp, {John M.} and Yoram Sorokin and Marshall Carpenter and Julie Lo and Ramin, {Susan M.} and Margaret Harper",
year = "2012",
month = "11",
doi = "10.1016/j.ajog.2012.08.001",
language = "English (US)",
volume = "207",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation

AU - Caritis, Steve N.

AU - Simhan, Hyagriv N.

AU - Zhao, Yuan

AU - Rouse, Dwight J.

AU - Peaceman, Alan M.

AU - Sciscione, Anthony

AU - Spong, Catherine Y.

AU - Varner, Michael W.

AU - Malone, Fergal D.

AU - Iams, Jay D.

AU - Mercer, Brian M.

AU - Thorp, John M.

AU - Sorokin, Yoram

AU - Carpenter, Marshall

AU - Lo, Julie

AU - Ramin, Susan M.

AU - Harper, Margaret

PY - 2012/11

Y1 - 2012/11

N2 - Objective: We sought to evaluate in women with twin gestation the relationship between 17-hydroxyprogesterone caproate (17-OHPC) concentration and gestational age at delivery and select biomarkers of potential pathways of drug action. Study Design: Blood was obtained between 24-28 weeks (epoch 1) and 32-35 weeks (epoch 2) in 217 women with twin gestation receiving 17-OHPC or placebo. Gestational age at delivery and concentrations of 17-OHPC, 17-hydroxyprogesterone, progesterone, C-reactive protein (CRP), and corticotrophin-releasing hormone were assessed. Results: Women with higher concentrations of 17-OHPC delivered at earlier gestational ages than women with lower concentrations (P <.001). Women receiving 17-OHPC demonstrated significantly higher (P =.005) concentrations of CRP in epoch 1 than women receiving placebo but CRP values were similar in epoch 2 in both groups. A highly significant (P <.0001) positive relationship was observed between 17-OHPC concentration and progesterone and 17-hydroxyprogesterone concentrations at both epochs. Corticotropin-releasing hormone concentrations did not differ by treatment group. Conclusion: 17-OHPC may adversely impact gestational age at delivery in women with twin gestation.

AB - Objective: We sought to evaluate in women with twin gestation the relationship between 17-hydroxyprogesterone caproate (17-OHPC) concentration and gestational age at delivery and select biomarkers of potential pathways of drug action. Study Design: Blood was obtained between 24-28 weeks (epoch 1) and 32-35 weeks (epoch 2) in 217 women with twin gestation receiving 17-OHPC or placebo. Gestational age at delivery and concentrations of 17-OHPC, 17-hydroxyprogesterone, progesterone, C-reactive protein (CRP), and corticotrophin-releasing hormone were assessed. Results: Women with higher concentrations of 17-OHPC delivered at earlier gestational ages than women with lower concentrations (P <.001). Women receiving 17-OHPC demonstrated significantly higher (P =.005) concentrations of CRP in epoch 1 than women receiving placebo but CRP values were similar in epoch 2 in both groups. A highly significant (P <.0001) positive relationship was observed between 17-OHPC concentration and progesterone and 17-hydroxyprogesterone concentrations at both epochs. Corticotropin-releasing hormone concentrations did not differ by treatment group. Conclusion: 17-OHPC may adversely impact gestational age at delivery in women with twin gestation.

KW - 17-hydroxyprogesterone caproate

KW - pharmacodynamics

KW - twin gestation

UR - http://www.scopus.com/inward/record.url?scp=84868154962&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868154962&partnerID=8YFLogxK

U2 - 10.1016/j.ajog.2012.08.001

DO - 10.1016/j.ajog.2012.08.001

M3 - Article

VL - 207

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 5

ER -